At this crisis point in history - what could possibly create these rare and extraordinary gains?

An Arizona multi-millionaire's revolutionary initiative is 
helping average Americans  find quick and lasting stock market success.

Since the Coronavirus came into our lives this slice of the stock market has given ordinary people the chance to multiply their money by 96% in 21 days on JP Morgan.

Stocks  | July 13, 2020

The case incidence of coronavirus is rising, raising fears that the initial economic reopenings were too much, too soon, and too fast. Adding to the nervous outlook, the White House has let it be known that it will seek a cap on future economic stimulus packages at $1 trillion. Considering that the last round of stimulus was upwards of $3 trillion, seeking to cap it at one-third that amount – at least party in the name of deficit control – sounds like a case of closing the barn door after the horses have bolted. It’s one more signal in a growing round of confusion.

At least some signals, however, are coming through loud and clear. Another signal is coming through from Wall Street’s analysts: There are still plenty of stocks to buy, with strong prospects to survive the corona crisis – and to do it with plenty of upside share potential.

We’ve used the TipRanks database to pull the details on three of these lesser-known, buy-rated stocks. Let’s find out what the analysts have to say about them.

Azek Company, Inc. (AZEK)

We’ll start with a company in the construction industry. Azek inhabits a niche that is going to do well as ‘social distancing’ becomes the norm. The company makes decking, patio, and outdoor products. With summer here, and indoor gatherings highly proscribed, the company took a calculated risk.

Azek went public in mid-June. The IPO was a big one, raising over $765 million despite the pandemic, and shares have gained in the weeks since. AZEK is up 15% since starting on the NYSE exchange. While the stock is impressive, there are some cautionary signs. Azek is highly leveraged, with over $1.2 billion in debt, nearly 25% of the company’s $4.5 billion total market cap. It’s clear that Azek is betting heavy on several factors: the V-shaped recovery, people’s desire to get together – safely, and that backyard recreational activities will be a winner this year.

Is that a good bet? Analyst Alex Rygiel of B. Riley FBR clearly thinks so. The analyst writes of Azek, “…we believe AZEK could experience industry-leading margin expansion over the next three years. We also believe the recent COVID-19 environment with stay-at-home and social distancing orders could create a tailwind for AZEK and the overall decking industry as more homeowners looks to expand their livable space outdoors and with the possible suburbanization of the population.”

Against this backdrop, Rygiel initiated coverage on AZEK shares with a Buy rating and a $38 price target, which implies room for 22% upside growth this year.

Overall, AZEK gets a Moderate Buy from the Wall Street analyst consensus. The stock has received 15 reviews in recent weeks, breaking down 10 to 5 in Buys versus Holds. Shares are currently trading for $31.1, and the average price target of $35.50 suggests a 14% one-year upside potential.

Ambarella (AMBA)

Now we move to the tech industry, where Ambarella is a small-cap design company in the semiconductor chip sector’s fabless segment. That’s a fancy way of saying that the company designs its chips, makes the prototypes, and farms out the mass production. Ambarella focuses on video compression, computer vision processors, and video compression – all important uses as companies and workers move heavily toward telecommuting. Ambarella’s chips also have applications in the video security monitoring and autonomous vehicle niches.

Ambarella saw sluggish earnings in 1H20, as the COVID-19 pandemic impacted supply chains, manufacturing facilities, and sales. That said, the company has found some tailwinds. Video AI and computer vision are growing segments, and the company has a solid position in both.

While earnings were down, revenues in Q1 beat the forecast, coming in at $54.6 million. Ambarella also has plenty of liquidity to combat the pandemic’s economic impact; the company finished Q1 with $411 million in cash on hand, up from $405 million at the end of 2019, and the free cash flow generated a healthy $7.6 million.

It’s the sector outlook, however, that attracted attention form Needham’s Quinn Bolton. The 5-star analyst, rated #8 overall in TipRanks’ database, likes what he sees in Ambarella, and upgraded his stance to Buy based on the strength of the Computer Vision segment.

We believe CV design activity remains robust. Professional security camera design wins represent the first wave of the CV production ramp and should drive CV revenue to ~10% of revenue in FY21 (CY20). The second CV wave, driven by the consumer security camera market, is expected to start in CY21 while the third CV wave, driven by Auto applications, is expected in CY22 and beyond,” Bolton commented.

Bolton backs his new Buy rating with $55 price target, indicating a 14% upside potential in the next 12 months.

Overall, the analyst consensus on AMBA is a Moderate Buy, based on a mix of reviews: 5 Buys, 4 Holds, and a single Sell. The shares have an average price target of $57.78, which implies a healthy 20% upside from the current trading price of $48.21.

Arthur J. Gallagher & Company (AJG)

Last on our list is an $18 billion global insurance broker and risk management firm, Arthur J. Gallagher. The company, based in the Chicago area, has a worldwide presence and is notable for being selected nine years running as one of the world’s most ethical companies.

As an insurance company, with a reputation for ethical behavior, Gallagher was particularly well-positioned to gain during the coronavirus pandemic scare. The company saw Q1 earnings of $1.83 per share, well above the $1.74 expectation, and also up 215% sequentially.

Deutsche Bank’s Phil Stefano sees AJG in position to continue growing, and upgrades his rating on the stock to a Buy. Supporting this, he writes, “We believe our margin expectation for Brokerage drives our Street high EPS estimates for the remainder of 2020 and 2021, with investors not fully appreciating the magnitude of the expense benefit impact to margins.”

Stefano’s price target backs up his Buy rating; at $120, it implies a 21% upside potential for the stock.

All in all, AJG has eight recent stock reviews, including 6 Buys and 2 Holds, giving the stock a consensus rating of Strong Buy. The stock is selling for $99.14, and the average price target of $108.38 indicates a possible 9% upside this year.

A revolutionary initiative is helping average Americans find quick and lasting stock market success.

275% in one week on XLF - an index fund for the financial sector. Even 583%, in 7 days on XHB… an ETF of homebuilding companies in the S&P 500. 

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

You might also like

Stocks | January 28

Stocks | January 28

Investing, Stocks | January 27

Investing | January 27